4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001450324-22-000004
CEO & President acquired 32,895 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Equels Thomas K · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-18 | Grant or award : show line 1 in the form | +32,895 | $0.76 | $25,000 | 382,704 | D |
Loading xslF345X03/primary_doc.xml…